Summary
The product Trenbolone Enanthate 200 mg/ml, manufactured by Unique Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number UN55447, was submitted by the reseller Optitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Trenbolone Enanthate, with a concentration of 209.29 mg/ml, exceeding the labeled claim of 200 mg/ml by 4.65%.
The testing process began on 31 October 2022, with the sample received on 4 November 2022, and analysis completed on 9 November 2022. The results confirm accurate dosing, but scrutiny of reseller-submitted samples is essential to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Trenbolone Enanthate 200 mg/ml
- Active Ingredient: Trenbolone Enanthate
- Batch Number: UN55447
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #25387
- Testing Ordered: 31 October 2022
- Sample Received: 4 November 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Optitropin.EU (Reseller)
- Analysis Paid For By: Optitropin.EU
Testing Results
- Specification: 200 mg/ml (as stated on the label)
- Measured Concentration: 209.29 mg/ml
- Accuracy: 104.65% (4.65% above the label claim)
- Variance: 4.65%
Verification Details
- Verification URL: https://janoshik.com/tests/25387_TW4GXRXR9EV6
Evaluation of Reseller-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by the reseller Optitropin.EU. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Trenbolone Enanthate 200 mg/ml is slightly overdosed, with a measured concentration of 209.29 mg/ml. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
